Major Stock Sale by Merit Medical Systems Insider!

Tip Ranks
2025.11.27 02:12
portai
I'm PortAI, I can summarize articles.

Fred Lampropoulos, an executive at Merit Medical Systems, sold 10,000 shares worth $880,300. The company is shifting strategy due to CMS deferring payment for a key product, impacting revenue but showing strong business momentum. Positive clinical trial results support product efficacy. Analysts rate MMSI as 'Outperform' despite challenges, with strong financial performance and strategic initiatives positioning it for growth.

New insider activity at Merit Medical Systems ( (MMSI) ) has taken place on November 26, 2025.

TipRanks Black Friday Sale

  • Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
  • Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off

EC Fred Lampropoulos recently sold 10,000 shares of Merit Medical Systems stock, amounting to a total transaction value of $880,300.

Recent Updates on MMSI stock

In recent developments for Merit Medical Systems, analysts have adjusted their price targets due to the company’s strategic pivot following a deferral by the U.S. Centers for Medicare & Medicaid Services (CMS) regarding the Transitional Pass-Through (TPT) payment for the WRAPSODY Cell-Impermeable Endoprosthesis. The deferral to 2027 prompted Merit to withdraw its TPT application and commence full U.S. commercialization of the product, aiming to enhance patient access and optimize adoption. This strategic shift is seen as a response to the delay in CMS approval, impacting the company’s potential revenue from Wrapsody but also reflecting strong core business momentum. Additionally, positive clinical trial results from the WAVE trial further support the product’s efficacy, potentially bolstering its market adoption.

Spark’s Take on MMSI Stock

According to Spark, TipRanks’ AI Analyst, MMSI is a Outperform.

Merit Medical Systems exhibits strong financial performance and positive earnings call highlights, which are the most significant factors driving the score. The technical analysis indicates stable momentum, while the high valuation suggests caution. Despite some challenges in specific segments and markets, the company’s strategic initiatives and financial health position it well for future growth.

To see Spark’s full report on MMSI stock, click here.

More about Merit Medical Systems

YTD Price Performance: -8.82%

Average Trading Volume: 657,501

Technical Sentiment Signal: Hold

Current Market Cap: $5.19B

Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer